Abstract
Most patients with primary antibody deficiency (PAD) suffer from less well-described and understood forms of hypogammaglobulinemia (unclassified primary antibody deficiency, unPAD). Because of the moderately decreased immunoglobulin levels compared to CVID, unPAD is generally considered to be clinically mild and not very relevant.
Objective
To describe our cohort of—mainly—unPAD patients, and to analyze whether subgroups can be identified.
Methods
Data were prospectively collected (February-2012 to June-2016) as part of a standardized, 1-day Care Pathway for suspected primary immunodeficiency. The TNO-AZL Questionnaire for Health-Related Quality of Life (HRQoL) was part of the pre-first-visit intake procedure.
Results
Three hundred and twenty patients were referred to the Care Pathway. Data from 23/27 children and 99/113 adults who were diagnosed with PAD and gave informed consent were available for analysis. 89/99 adults had unPAD, the majority (74%) were female and 44% already showed bronchiectasis. HRQoL was significantly decreased in all domains, meaning that a lot of unPAD patients had to cope simultaneously with pain, negative feelings and impairments in cognition, home management tasks, sleep, social interaction, and work. The most prominently impaired HRQoL domain was vitality, indicating these patients feel extremely tired and worn out.
Conclusion
These results highlight the need for more attention to the potential patient burden of unPADs. A larger cohort is needed to increase our understanding of unPADs and to analyze whether distinct subgroups can be identified. For now, it is important for the clinician to acknowledge the existence of unPAD and be aware of its potential consequences, in order to timely and appropriately manage its effects and complications.
| Original language | English |
|---|---|
| Article number | 2384 |
| Number of pages | 9 |
| Journal | Frontiers in Immunology |
| Volume | 9 |
| DOIs | |
| Publication status | Published - 2018 |
Fingerprint
Keywords
- CHILDREN
- CLASSIFICATION
- COMMON VARIABLE IMMUNODEFICIENCY
- DISEASE
- DISORDERS
- IDENTIFICATION
- IGA DEFICIENCY
- PATIENT
- QUALITY-OF-LIFE
- RESPONSES
- common variable immunodeficiency disorders
- hypogammaglobulinemia
- immunodeficiency
- pneumococcal vaccination response
- primary antibody deficiency
- primary immunodeficiency
- unclassified primary antibody deficiency
Cite this
}
Mild hypogammaglobulinemia can be a serious condition. / Janssen, L.M.A.; Bassett, P.; Macken, T.; van Esch, J.; Pruijt, J.; Knoops, A.; Sköld, M.; Parker, A.; de Vries, J.; de Vries, Esther.
In: Frontiers in Immunology, Vol. 9, 2384, 2018.Research output: Contribution to journal › Article › Scientific › peer-review
TY - JOUR
T1 - Mild hypogammaglobulinemia can be a serious condition
AU - Janssen, L.M.A.
AU - Bassett, P.
AU - Macken, T.
AU - van Esch, J.
AU - Pruijt, J.
AU - Knoops, A.
AU - Sköld, M.
AU - Parker, A.
AU - de Vries, J.
AU - de Vries, Esther
PY - 2018
Y1 - 2018
N2 - BackgroundMost patients with primary antibody deficiency (PAD) suffer from less well-described and understood forms of hypogammaglobulinemia (unclassified primary antibody deficiency, unPAD). Because of the moderately decreased immunoglobulin levels compared to CVID, unPAD is generally considered to be clinically mild and not very relevant.ObjectiveTo describe our cohort of—mainly—unPAD patients, and to analyze whether subgroups can be identified.MethodsData were prospectively collected (February-2012 to June-2016) as part of a standardized, 1-day Care Pathway for suspected primary immunodeficiency. The TNO-AZL Questionnaire for Health-Related Quality of Life (HRQoL) was part of the pre-first-visit intake procedure.ResultsThree hundred and twenty patients were referred to the Care Pathway. Data from 23/27 children and 99/113 adults who were diagnosed with PAD and gave informed consent were available for analysis. 89/99 adults had unPAD, the majority (74%) were female and 44% already showed bronchiectasis. HRQoL was significantly decreased in all domains, meaning that a lot of unPAD patients had to cope simultaneously with pain, negative feelings and impairments in cognition, home management tasks, sleep, social interaction, and work. The most prominently impaired HRQoL domain was vitality, indicating these patients feel extremely tired and worn out.ConclusionThese results highlight the need for more attention to the potential patient burden of unPADs. A larger cohort is needed to increase our understanding of unPADs and to analyze whether distinct subgroups can be identified. For now, it is important for the clinician to acknowledge the existence of unPAD and be aware of its potential consequences, in order to timely and appropriately manage its effects and complications.
AB - BackgroundMost patients with primary antibody deficiency (PAD) suffer from less well-described and understood forms of hypogammaglobulinemia (unclassified primary antibody deficiency, unPAD). Because of the moderately decreased immunoglobulin levels compared to CVID, unPAD is generally considered to be clinically mild and not very relevant.ObjectiveTo describe our cohort of—mainly—unPAD patients, and to analyze whether subgroups can be identified.MethodsData were prospectively collected (February-2012 to June-2016) as part of a standardized, 1-day Care Pathway for suspected primary immunodeficiency. The TNO-AZL Questionnaire for Health-Related Quality of Life (HRQoL) was part of the pre-first-visit intake procedure.ResultsThree hundred and twenty patients were referred to the Care Pathway. Data from 23/27 children and 99/113 adults who were diagnosed with PAD and gave informed consent were available for analysis. 89/99 adults had unPAD, the majority (74%) were female and 44% already showed bronchiectasis. HRQoL was significantly decreased in all domains, meaning that a lot of unPAD patients had to cope simultaneously with pain, negative feelings and impairments in cognition, home management tasks, sleep, social interaction, and work. The most prominently impaired HRQoL domain was vitality, indicating these patients feel extremely tired and worn out.ConclusionThese results highlight the need for more attention to the potential patient burden of unPADs. A larger cohort is needed to increase our understanding of unPADs and to analyze whether distinct subgroups can be identified. For now, it is important for the clinician to acknowledge the existence of unPAD and be aware of its potential consequences, in order to timely and appropriately manage its effects and complications.
KW - CHILDREN
KW - CLASSIFICATION
KW - COMMON VARIABLE IMMUNODEFICIENCY
KW - DISEASE
KW - DISORDERS
KW - IDENTIFICATION
KW - IGA DEFICIENCY
KW - PATIENT
KW - QUALITY-OF-LIFE
KW - RESPONSES
KW - common variable immunodeficiency disorders
KW - hypogammaglobulinemia
KW - immunodeficiency
KW - pneumococcal vaccination response
KW - primary antibody deficiency
KW - primary immunodeficiency
KW - unclassified primary antibody deficiency
U2 - 10.3389/fimmu.2018.02384
DO - 10.3389/fimmu.2018.02384
M3 - Article
VL - 9
JO - Frontiers in Immunology
JF - Frontiers in Immunology
SN - 1664-3224
M1 - 2384
ER -